1952.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 04:08):

Stats
Today's Volume	3.98M
Average Volume	4.56M
Market Cap	6.89B
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-7.38
ATR14	HKD0.0300 (0.14%)

Volume Correlation

Long: -0.27 (neutral)

Short: -0.37 (neutral)

Signal:(39.035) Neutral

Everest Medicines Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Everest Medicines Limited Correlation - Currency/Commodity

0.36
( neutral )

0.34
( neutral )

0.00
( neutral )

0.51
( weak )

-0.76
( moderate negative )

-0.03
( neutral )

Everest Medicines Limited Financials

Annual	2022
Revenue:	HKD12.79M
Gross Profit:	HKD8.15M (63.69 %)
EPS:	HKD-0.830

Q2	2023
Revenue:	HKD4.45M
Gross Profit:	HKD2.79M (62.70 %)
EPS:	HKD-0.700

Q1	2023
Revenue:	HKD4.45M
Gross Profit:	HKD2.79M (62.70 %)
EPS:	HKD-0.700

Q4	2022
Revenue:	HKD5.87M
Gross Profit:	HKD3.73M (63.56 %)
EPS:	HKD0.700

Financial Reports:

No articles found.

Everest Medicines Limited

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.